Stocklytics Platform
Asset logo for symbol DVA
DaVita
DVA62
$149.98arrow_drop_up0.83%$1.23
S&P500
Asset logo for symbol DVA
DVA62

$149.98

arrow_drop_up0.83%
Key Stats
Open$149.16
Prev. Close$148.74
EPS9.40
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range148.31
151.44
52 Week Range71.51
156.44
Ratios
EPS9.40
Fundamentals
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

DVAarrow_drop_down2.02%
US Healthcare Sectorarrow_drop_down0.64%
US Marketarrow_drop_down2.07%
check_circle

DVA / Market

DVA exceeded the US Market which returned -2.07% over the last twenty four hours.
warning

DVA / Healthcare Sector

DVA lose to the US Healthcare sector which returned -0.64% over the last twenty four hours.

DaVita (DVA) Statistics

DaVita Inc, commonly known as DaVita, is a healthcare company that specializes in kidney care. The company provides dialysis services to patients with chronic kidney failure and end-stage renal disease (ESRD). DaVita operates a network of outpatient dialysis centers across the United States, serving approximately 204,000 patients as of December 31, 2020. The company's mission is to improve patients' quality of life by delivering superior clinical outcomes and holistic care. DaVita has been recognized for its patient-centered approach and commitment to fostering a supportive community.
DaVita's stock performance has shown resilience over the years. Despite facing challenges in the healthcare industry, the company has consistently delivered strong financial results. As of December 31, 2020, DaVita's stock had a market capitalization of approximately $12.8 billion. The company's valuation metrics indicate its strong position in the market. Its price-to-earnings ratio stands at 17.50, reflecting investors' confidence in its potential for growth and profitability. DaVita's enterprise value to EBITDA ratio, a measure of its overall financial health, is 9.15, further highlighting its solid fundamentals.
add DaVita  to watchlist

Keep an eye on DaVita

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How much debt does DaVita (DVA) have?

DaVita (DVA) has a total debt of $11.68B. The net debt, which accounts for cash and cash equivalents against the total debt, is $11.17B.
help

How has DaVita (DVA) stock's performance compared to its sector and the market over the past year?

Over the past year, DaVita (DVA) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.97%, DaVita has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 58.78%, it has fallen short of the market average. This comparison highlights DaVita 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of DaVita (DVA) stock?

The PE (Price to Earnings) ratio of DaVita (DVA) is currently 15.96. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of DaVita (DVA) stock?

The Earnings Per Share (EPS) for DaVita (DVA), calculated on a diluted basis, is $9.4. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of DaVita (DVA) stock?

The operating margin for DaVita (DVA) is 16.2%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of DaVita (DVA) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of DaVita (DVA) is $2.55B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media